Abstract
Purpose
Patients with advanced cancer have increased life expectancy but suffer from ongoing burden. Depressive symptomatology is their most common mental health concern. The Ottawa Palliative Rehabilitation Program (PRP) offers rehabilitation for this population. It offers 8 weeks of individualized interdisciplinary rehabilitation, post cancer treatment. Interventions include medical (physician and nurse), physiotherapy, occupational therapy, dietary, and social work using a general self-efficacy framework. Pilot data suggest benefits in a range of domains, including ratings of feeling “depressed.” We examined whether reduced symptomatology was maintained 3 months after PRP completion.
Methods
Participants with advanced heterogeneous cancers who completed the PRP were mailed the Hospital Anxiety and Depression Scale (among others) 3-month post-PRP (n = 44). Demographic and medical information were obtained from patient files.
Results
There was a significant linear trend (mean T1: 6.79 ± 2.29; T2: 5.23 ± 3.06; T3: 4.59 ± 3.34; p = 0.007) with statistically and clinically significant decreases in reported depressive symptomatology between T1 and T2 (p = 0.042) and T1 and T3 (p = 0.007). There was a significant decreases in number of cases reporting symptomatology scores in the clinical range from T1 to T3 (p = 0.038).
Conclusion
Patients who undergo a palliative rehabilitation program may experience relief of mild depressive symptomatology, maintainable 3-month post-PRP. The sample was exhibiting mild symptomatology and these results may not be generalizable to those with higher scores; a lack of specialized psychosocial clinician may have affected the acquired sample. Experimental designs are needed to more thoroughly compare these findings to independent rehabilitation interventions.
Similar content being viewed by others
References
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., et al. (2011). FOLFIRINOX versus Gemcitabine for metastatic pancreatic cancer. New England Journal of Medicine. doi:10.1056/NEJMoa1011923.
Tangen, C., Faulkner, J., Crawford, E. D., Thompson, I., Hirano, D., Eisenberger, M., & Hussain, M. (2003). Ten-year survival in patients with metastatic prostate cancer. Clinical Genitourinary Cancer, 2, 41–45.
Esper, P. (2010). Symptom clusters in individuals living with advanced cancer. Seminars in Oncology Nursing. doi:10.1016/j.soncn.2010.05.002.
Haylock, P. J. (2010). Advanced cancer: Emergence of a new survivor population. Seminars in Oncology Nursing. doi:10.1016/j.soncn.2010.05.008.
Mayer, M. (2010). Lessons learned from the metastatic breast cancer community. Seminars in Oncology Nursing. doi:10.1016/j.soncn.2010.05.004.
Park, E. M., & Rosenstein, D. L. (2014). Living with advanced cancer: Unmet survivorship needs. North Carolina Medical Journal, 75, 279–282.
Bruera, E., & Yennurajalingam, S. (2012). Palliative care in advanced cancer patients: How and when? The Oncologist. doi:10.1634/theoncologist.2011-0219.
Wilson, K.G., Lander, M., Chochinov, H.M. (2009). Diagnosis and management of depression in palliative care. In H.M. Chochinov, & W. Breitbart (Eds.). Psychiatry in palliative care (2nd edn, pp. 39–69). New York, NY: Oxford University Press.
Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2011). Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. Lancet Oncology. doi:10.1016/S1470-2045(11)70002-X.
Rodin, G. (2013). Research on psychological and social factors in palliative care: An invited commentary. Palliative Medicine. doi:10.1177/0269216313499961.
Fils, J. M., Penick, E. C., Nickel, E. J., Othmer, E., DeSouza, C., Gabrielli, W. F., & Hunter, E. E. (2010). Minor versus major depression: A comparative clinical study. Primary Care Companion to Journal of Clinical Psychiatry. doi:10.4088/PCC.08m00752blu.
Delgado-Guay, M., Parsons, H. A., Li, Z., Palmer, J. L., & Bruera, E. (2009). Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Supportive Care in Cancer. doi:10.1007/s00520-008-0529-7.
Pinquart, M., & Duberstein, P. R. (2010). Depression and cancer mortality: A meta-analysis. Psychological Medicine. doi:10.1017/S0033291709992285.
Satin, J. R., Linden, W., & Phillips, M. J. (2010). Depression as a predictor of disease progression and mortality in cancer patients: A meta-analysis. Cancer. doi:10.1002/cncr.24561.
Meeks, T. W., Vahia, I. V., Lavretsky, H., Kulkarni, G., & Jeste, D. V. (2011). A tune in “a minor” can “b major”: A review of epidemiology, illness course, and public health implications of subthreshold depression in older adults. Journal of Affective Disorders. doi:10.1016/j.jad.2010.09.015.
Currier, M. B., & Nemeroff, C. B. (2014). Depression as a risk factor for Cancer: From pathophysiological advances to treatment implications. Annual Review of Medicine. doi:10.1146/annurev-med-061212-171507.
Li, M., & Rodin, G. (2010). Depression and illness. In J. M. Suis, K. W. Davidson & R. M. Kaplan (Eds.), Handbook of health psychology and behavioral medicine (pp. 217–233). New York: Guilford.
Chasen, M., Feldstain, A., Gravelle, D., MacDonald, N., & Pereira, J. (2013). An interprofessional palliative care oncology rehabilitation program: Effects on function and predictors of program completion. Current Oncology. doi:10.3747/co.20.1607.
Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review, 84, 191–215.
Bandura, A. (2009). Self-efficacy. In I. B. Weiner & W. E. Craighead (Eds.), The Corsini Encyclopedia of Psychology (p. 1534). New York, NY: John Wiley & Sons, Inc.
Luszczynska, A., Gutiérrez-Dona, B., & Schwarzer, R. (2005). General self-efficacy in various domains of human functioning: Evidence from five countries. International Journal of Psychology. doi:10.1080/00207590444000041.
Feldstain, A., Lebel, S., & Chasen, M. R. (2016). An interdisciplinary palliative rehabilitation intervention bolstering general self-efficacy to attenuate symptoms of depression in patients living with advanced cancer. Supportive Care in Cancer. doi:10.1007/s00520-015-2751-4.
Lynn, J., & Adamson, D.M. (2003). Living well at the end of life. Adapting health care to serious chronic illness in old age. Retrieved 15 July, 2014, from http://www.rand.org/pubs/white_papers/WP137.
Krogh, J., Nordentoft, M., Sterne, J.A.C., & Lawlor, D. A. (2011). The effect of exercise in clinically depressed adults: Systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Psychiatry. doi:10.4088/JCP.08r04913blu.
Mead, G. E., Morley, W., Campbell, P., Greig, C. A., McMurdo, M., & Lawlor, D. A. (2009). Exercise for depression. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD004366.pub4.
Mishra, S. I., Scherer, R. W., Geigle, P. M., Berlanstein, D. R., Topaloglu, O., Gotay, C. C., & Snyder, C. (2010). Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD007566.pub2.
Rimer, J., Dwan, K., Lawlor, D. A., Greig, C. A., McMurdo, M., Morley, W., & Mead, G. E. (2012). Exercise for depression. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD004366.pub5.
Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., & Carbone, P. P. (1982). Toxicity and response criteria of the Eastern cooperative oncology group. American Journal of Clinical Oncology, 5, 649–655.
Zigmond, A. S., & Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67, 361–370.
Mitchell, A. J., Meader, N., & Symonds, P. (2010). Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: A meta-analysis. Journal of Affective Disorders. doi:10.1016/j.jad.2010.01.067.
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the Hospital Anxiety and Depression Scale: An updated literature review. Journal of Psychosomatic Research, 52, 69–77.
Luckett, T., Butow, P., King, M., Oguchi, M., Heading, G., Hackl, N., et al. (2010). A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses. Supportive Care in Cancer. doi:10.1007/s00520-010-0932-8.
Vodermaier, A., & Millman, R. D. (2011). Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: A systematic review and meta-analysis. Supportive Care in Cancer. doi:10.1007/s00520-011-1251-4.
Faul, F., Erdfelder, E., Lang, A. G., & Buchner, A. (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavioral Research Methods (San Diego, Calif.). doi:10.3758/BF03193146.
Graham, J. W. (2012). Missing data analysis and design. New York: Springer.
Sinharay, S., Stern, H. S., & Russell, D. (2001). The use of multiple imputation for the analysis of missing data. Psychological Methods. doi:10.1037/1082-989X.6.4.317.
Linden, A. (2013). Assessing regression to the mean effects in health care initiatives. BMC Medical Research Methodology. doi:10.1186/1471-2288-13-119.
Rocconi, L. M., & Ethington, C. A. (2009). Assessing longitudinal change: Adjustment for regression to the mean effects. Research in Higher Education. doi:10.1007/s11162-009-9119-x.
Sorensen, J. B., Klee, M., Palshof, T., & Hansen, H. H. (1993). Performance status assessment in cancer patients. An inter-observer variability study. British Journal of Cancer. doi:10.1038/bjc.1993.140.
Puhan, M. A., Frey, M., Büchi, S., & Schünemann, H. J. (2008). The minimal important difference of the hospital anxiety and depressive scale in patients with chronic obstructive pulmonary disease. Health and Quality of Life Outcomes. doi:10.1186/1477-7525-6-46.
Cancer Journey Portfolio. (2012). Screening for Distress, the 6th Vital Sign: A Guide to Implementing Best Practices in Person-Centred Care. Retrieved 22 Dec, 2016 http://www.cancerview.ca.
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., & Gralow, J. (2008). Major depression after breast cancer: A review of epidemiology and treatment. General Hospital Psychiatry. doi:10.1016/j.genhosppsych.2007.10.008.
Rodriguez, A. M., Mayo, N. E., & Gagnon, B. (2013). Independent contributors to overall quality of life in people with advanced cancer. British Journal of Cancer. doi:10.1038/bjc.2013.146.
Jaremka, L. M., Fagundes, C. P., Glaser, R., Bennett, J. M., Malarkey, W. B., & Kiecolt-Glaser, J. K. (2013). Loneliness predicts pain, depression, and fatigue: Understanding the role of immune dysregulation. Psychoneuroendocrinology. doi:10.1016/j.psyneuen.2012.
Acknowledgements
We thank the members of the Palliative Rehabilitation team: Dr. Paula Enright, Debbie Gravelle, Teresa Lee, Lisa Savage-Larose, Caroline Richardson, Cecelia Cranston, Anne-Marie Burns, Rita Finnigan, Maria Delgadillo for their clinical contributions; Josée Desjardins, Samantha Zinkie, Danielle Sinden, and Sylvie Bisaillon for their administrative support; Dr. Neil MacDonald and Dr. Ravi Bhargava for their academic contributions; and Dr. Catherine Bielajew, Dr. Keith Wilson, Dr. Mary Egan, and Dr. Nicole Culos-Reed who provided their feedback on this manuscript as evaluators of author AF’s doctoral thesis. This research was funded by contributions to the Palliative Rehabilitation Program from Bruyère Continuing Care, The Bruyère Research Institute, and the Bruyère Foundation. Author AF is currently funded through a post-doctoral clinical Fellowship from the Alberta Cancer Foundation, the Department of Oncology, CancerControl Alberta, and Alberta Health Services.
Funding
This research was funded by contributions to the Palliative Rehabilitation Program from Bruyère Continuing Care, The Bruyère Research Institute, and the Bruyère Foundation. Author AF is currently funded through a clinical Fellowship from the Alberta Cancer Foundation, the Department of Oncology, CancerControl Alberta, and Alberta Health Services.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Rights and permissions
About this article
Cite this article
Feldstain, A., Lebel, S. & Chasen, M.R. The longitudinal course of depression symptomatology following a palliative rehabilitation program. Qual Life Res 26, 1809–1818 (2017). https://doi.org/10.1007/s11136-017-1531-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-017-1531-7